Akcea Therapeutics, Inc. Restructuring Costs
Akcea Therapeutics, Inc. reported Restructuring Costs of $2.15 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-02.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2020-03-02
- Akcea Therapeutics, Inc. restructuring costs for the quarter ending 2018-12-31 was -$150.00K.
- Akcea Therapeutics, Inc. restructuring costs for fiscal 2018 was $2.15M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 9 month | Restructuring Costs 12 month |
|---|---|---|---|
| 2018-12-31 | -$150.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $2.15M 10-K · filed 2020-03-02 | |
| 2018-09-30 | $2.30M 10-Q · filed 2018-11-06 |